|
|
Synthesis and cytotoxicity studies of newly designed benzyl-hydroquinone derivatives
Olivier Tasseau
,
Paul Mosset
,
Sophie C Barillé-Nion
,
Fabien Gautier
,
Philippe Juin
et al.
Journal articles
hal-01771097v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Preliminary Studies on the Activity of Mixed Polyphenol-Heterocyclic Systems Against B16-F10 Melanoma Cancer Cells
Duc Duy Vo
,
Isabelle Rouaud
,
Françoise Lohézic-Le Dévéhat
,
Fabien Gautier
,
Sophie Barillé-Nion
et al.
Medicinal Chemistry, 2016
Journal articles
inserm-01406309v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Synthesis of new mixed phenol/heterocyclic derivatives and studies of their activity as inhibitors of Bax/Bcl-xL interaction
Duc Duy Vo
,
Fabien Gautier
,
Sophie Barillé-Nion
,
Philippe Juin
,
Nicolas Levoin
et al.
Journal articles
hal-01114411v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Design, synthesis and biological evaluation of new inhibitors of Bax/Bcl-xL interaction in cancer cells.
Duc Duy Vo
,
Fabien Gautier
,
Sophie Barillé-Nion
,
Philippe Juin
,
Nicolas Levoin
et al.
Journal articles
hal-01116303v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Hemisynthesis of selected embelin analogs and investigation of their proapoptotic activity against cancer cells
Guillaume Viault
,
Katragadda Suresh Babu
,
Fabien Gautier
,
Sophie Barillé-Nion
,
Philippe Juin
et al.
Journal articles
hal-01147397v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A combination of in-silico and SAR studies to identify binding hot spots of Bcl-xL inhibitors
Nicolas Levoin
,
Duc Duy Vo
,
Fabien Gautier
,
Sophie Barillé-Nion
,
Philippe Juin
et al.
Journal articles
hal-01133213v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Corrigendum to “Synthesis of new mixed phenol/heterocyclic derivatives and studies of their activity as inhibitors of Bax/Bcl-xL interaction” [Tetrahedron 70 (2014) 301–311]
Duc Duy Vo
,
Fabien Gautier
,
Sophie Barillé-Nion
,
Philippe Juin
,
Nicolas Levoin
et al.
Journal articles
hal-01153823v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|